Why Shares of Bausch Health Soared Wednesday

Why Shares of Bausch Health Soared Wednesday

Source: 
Motley Fool
snippet: 
  • Bausch could get to keep its patent for an IBS drug for another six years.
  • The drug brought in nearly $400 million in the first quarter.
  • Bausch is predicting revenue will rise between 2.8% and 5% this year.